| Early AMD | Late AMD | Total AMD | Normal |
---|---|---|---|---|
ARMS2 Homozygous T (risk) | 11/60 (18%) | 19/101 (19%) | 30/161 (19%) | 10/164 (6%) |
ARMS2 Homozygous G | 21/60 (35%) | 24/101 (24%) | 45/161 (28%) | 83/164 (51%) |
ARMS2 Heterozygous | 28/60 (47%) | 58/101 (57%) | 86/161 (53%) | 71/164 (43%) |
OR (p-value) | 1.81 (0.07) | 3.13 (0.0001) | 4.72 (0.00001) | Â |
CFH Homozygous C (risk) | 11/55 (20%) | 18/94 (19%) | 29/97 (20%) | 16/163 (9.8%) |
CFH Homozygous T | 23/55 (42%) | 29/94 (31%) | 52/97 (35%) | 85/163 (52%) |
CFH Heterozygous | 21/55 (38%) | 47/94 (50%) | 68/97 (45%) | 62/163 (38%) |
OR (p-value) | 1.27 (0.54) | 2.05 (0.014) | 1.71 (0.027) | Â |